sur MedMira, Inc. (CVE:MIR)
MedMira Joins Forces with MediGroup to Expand Reach in the US
MedMira Inc., a Halifax-based diagnostic company, has announced a new partnership with MediGroup, a major US healthcare group purchasing organization. This collaboration grants MedMira access to over 44,000 existing MediGroup customers, enhancing its market reach significantly.
MediGroup, established in 1999, is renowned for offering competitive pricing and comprehensive access to medical supplies in the US. The partnership aims to provide clients with affordable access to MedMira’s rapid diagnostic products, noting the immediate availability of the Reveal® G4 HIV-1/2 antibody rapid test.
The Reveal® G4 HIV test leverages MedMira's patented Rapid Vertical Flow Technology, featuring high reliability by eliminating false negatives. MedMira CEO, Hermes Chan, expressed optimism about this venture to broaden their service and product reach.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de MedMira, Inc.